Opportunity Overview

Předmětem plnění veřejné zakázky jsou průběžné dodávky léčivého přípravku s obsahem účinné látky aflibercept (ATC S01LA05) pro léčbu pacientů ve schválených indikacích dle SPC platného ke dni podání nabídek, v rozsahu dle potřeb zadavatele. Cílem zadavatele je zajistit pro svou činnost průběžné dodávky léčivých přípravků pro léčbu pacientů po dobu 1 roku od nabytí účinnosti rámcové kupní smlouvy.

This Czech Republic Pharmaceuticals opportunity is one most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agency	Nemocnice Kyjov, Příspěvková Organizace
Country	Czech Republic
Category	Pharmaceuticals
Estimated value	$466,945
Published	August 20, 2026
Procurement stage	Request for Proposal (RFP)
Response due	September 21, 2026
Status	Open — accepting responses
Original language	Czech — members read it in their own language
Official source	View original notice
Last verified	September 20, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Czech Republic market overview →Browse all categories →

Related Opportunities in Czech Republic

Czechia – Pharmaceutical products

See every Czech Republic Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Czech Republic Pharmaceuticals intelligence report in your inbox

A personalized report on Czech Republic Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.